Literature DB >> 9253904

Retinal large vessel oxygen saturations correlate with early blood loss and hypoxia in anesthetized swine.

K R Denninghoff1, M H Smith, R A Chipman, L W Hillman, P M Jester, C E Hughes, F Kuhn, L W Rue.   

Abstract

BACKGROUND: Noninvasive monitoring would likely improve trauma care. Using laser technology, we monitored the oxygen saturation in retinal vessels during exsanguination and hypoxia.
METHODS: Seven anesthetized swine were bled at 0.4 mL/kg/min for 40 minutes. During exsanguination, retinal venous saturation (SrvO2) was measured using an eye oximeter, and central venous saturation (SvO2) was measured using a fiber-optic catheter. After the shed blood was reinfused, the FiO2 was progressively decreased from 0.97 to 0.07. Femoral artery oxygen saturation (SaO2) and retinal artery oxygen saturation (SraO2) were measured at each increment.
RESULTS: During exsanguination, SrvO2 correlated with blood loss (r = -0.93) and SvO2 (r = 0.94). SraO2 correlated with SaO2 during incremental hypoxia (R2 = 0.93 +/- 0.15).
CONCLUSIONS: In this model of exsanguination, retinal venous oxygen saturation correlates with blood volume and with central venous oxygen saturation. The SraO2 correlates with SaO2 during graded hypoxia. Use of an eye oximeter to noninvasively monitor trauma patients appears promising and warrants further study.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9253904     DOI: 10.1097/00005373-199707000-00009

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  2 in total

1.  Retinal oximeter for the blue-green oximetry technique.

Authors:  Kurt R Denninghoff; Katarzyna B Sieluzycka; Jennifer K Hendryx; Tyson J Ririe; Lawrence Deluca; Russell A Chipman
Journal:  J Biomed Opt       Date:  2011-10       Impact factor: 3.170

2.  Automatic analysis of normative retinal oximetry images.

Authors:  J R Harish Kumar; Chandra Sekhar Seelamantula; Ashwin Mohan; Rohit Shetty; T J M Berendschot; Carroll A B Webers
Journal:  PLoS One       Date:  2020-05-18       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.